Atlas Trials

Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension

Clinical trial NCT00890591 · COMPLETED

Trial details

NCT number
NCT00890591
Sponsor
Daiichi Sankyo
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Essential Hypertension
Start date
2006-08-01
Primary completion
2007-06-01
Enrollment
144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.